Rationale Placebo responses are complex psychobiological phenomena and often involve
patient expectation of benefit. With continuous positive airway pressure (CPAP) treatment of …

We evaluated factors associated with subjective and objective sleepiness at baseline and
after 6 months of continuous positive airway pressure (CPAP) therapy in patients with …

Background: Obstructive sleep apnoea syndrome (OSAS) affects an estimated 2–4% of the
middle aged population. Meta-analyses of randomised controlled trials have shown that the …

Study objectives Continuous positive airway pressure (CPAP) therapy has become the
treatment of choice for obstructive sleep apnea (OSA). However, the efficacy of CPAP …

Objectives: Complaints of fatigue are frequent in patients with obstructive sleep apnea
(OSA); however, the impact of continuous positive airway pressure (CPAP) on fatigue …

There are limited data on the evolution of obstructive sleep apnoea (OSA) during continuous
positive airway pressure (CPAP) therapy and whether this treatment is required every night …

Objectives (1) To compare the continuous positive airway pressure (CPAP) requirement at
the time of diagnosis (T 0), after 2 weeks (T 2), and after 4 weeks (T 4) of CPAP treatment, in …

BACKGROUND: Continuous positive airway pressure (CPAP) improves daytime sleepiness
in patients with obstructive sleep apnoea (OSA). The effect of CPAP on physical activity is …

BACKGROUND Patients with the sleep apnoea/hypopnoea syndrome (SAHS) report
improved sleepiness, cognitive function, and psychological well being after continuous …

Introduction Continuous positive airway pressure (CPAP) is currently the treatment of choice
for sleepiness in patients with obstructive sleep apnoea (OSA); however, adherence is often …